Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02812537
Other study ID # 69HCL16_0136
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 20, 2019
Est. completion date May 2028

Study information

Verified date May 2023
Source Hospices Civils de Lyon
Contact Yannis Gansel, MD
Phone 472129562
Email yannis.gansel@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Conduct disorders are defined as "repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate norms are violated". So defined, these disorders are at the crossroads of psychiatry, social field and justice. Conduct disorder management is a public health issue and a societal question. Conduct disorders affect 5 to 9% of 15-year old boys. Care management of children and adolescents admitted for disruptive behaviors in emergency rooms is an issue. No consensus or official recommendation exists. However, use of emergency care in this context is increasing in most western countries and it exposes to several risks (inappropriate use of hospitalizations, social rupture, ignorance of comorbidities and suicide risk). The Trajectories project is designed to describe children and adolescents with disruptive behaviors, their care management and to follow their life trajectory and psychiatric evolution after admission to emergency rooms. Better understanding this population will improve their medical and social care management, thereby giving professionals the right tools. The main objective of this project is to implement a multidisciplinary and integrative research combining clinical considerations and social sciences to determine the "trajectory" of this population.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date May 2028
Est. primary completion date May 2028
Accepts healthy volunteers No
Gender All
Age group N/A to 16 Years
Eligibility Inclusion Criteria: - Children and adolescents less than 16 years old - Children and adolescents admitted to emergency rooms for aggressiveness, violence, fugue or theft Exclusion Criteria: - Children and adolescents admitted to emergency rooms for a reason not directly link with aggressiveness, violence, fugue or theft - Opposition to the subject or the family to participate to this research

Study Design


Related Conditions & MeSH terms


Intervention

Other:
patients with conduct disorders
interview with a specialist

Locations

Country Name City State
France Hospices Civils de Lyon Bron

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of new admissions to emergency rooms for aggressiveness, violence, fugue or theft Six months follow-up of these children and adolescents in their future trajectory after the first admission to emergency room for disruptive behavior 6 months
Secondary Age of the children and adolescents admitted to emergency rooms for aggressiveness, violence, fugue or theft mean age Day 0
Secondary Gender of the children and adolescents admitted to emergency rooms for aggressiveness, violence, fugue or theft Day 0
Secondary Number of children and adolescents precisely diagnosed with " behavior/conduct disorder Day 0
Secondary Number of hospitalization following the admission Day 0
Secondary number of patients admitted to emergency rooms for aggressiveness Day 0
Secondary number of patients admitted to emergency rooms for violence Day 0
Secondary number of patients admitted to emergency rooms for fugue Day 0
Secondary number of patients admitted to emergency rooms for theft Day 0
Secondary number of suicide attempts 24 months
Secondary number of patients with disruptive behavior recurrence 24 months
Secondary evolution of the CBCL score 24 months
See also
  Status Clinical Trial Phase
Completed NCT00250354 - A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation Phase 3
Completed NCT03698240 - Mindfulness-based Program for Children With Disruptive Behavior Disorder N/A
Completed NCT01750996 - Strongest Families Finland Canada: Family-based Prevention and Treatment Program of Early Childhood Disruptive Behavior Phase 1/Phase 2
Recruiting NCT06373484 - Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents N/A
Completed NCT02783560 - Behavioral Sleep Intervention in Children With Disruptive Behaviors N/A
Recruiting NCT04298437 - Addressing Depression and Positive Parenting Techniques (ADAPT) N/A
Completed NCT02704221 - Enhancing the Outcomes of a Behavioral Parent Training Intervention N/A
Completed NCT02488499 - Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project) N/A
Completed NCT00236470 - A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders Phase 3
Recruiting NCT04113161 - Navigating Resource-Constrained Systems and Communities to Promote the Behavioral Health of Black Youth N/A
Enrolling by invitation NCT05425381 - Improving Social, Emotional, Behavioral, and Academic Functioning N/A
Completed NCT03796663 - Mindful Parenting and Parent Training Program Study N/A
Completed NCT00266552 - A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation Phase 3